de GreyADNJ. Commentary on some recent theses relevant to combating aging. Rejuvenation Res, 2009; 12:53–58.
2.
de GreyADNJ. Commentary on some recent theses relevant to combating aging. Rejuvenation Res, 2009; 12:149–154.
3.
de GreyADNJ. Commentary on some recent theses relevant to combating aging: June 2009. Rejuvenation Res, 2009; 12:221–225.
4.
de GreyADNJ. Commentary on some recent theses relevant to combating aging: August 2009. Rejuvenation Res, 2009; 12:289–293.
5.
de GreyADNJ. Commentary on some recent theses relevant to combating aging: October 2009. Rejuvenation Res, 2009; 12:367–370.
6.
de GreyADNJ. Commentary on some recent theses relevant to combating aging: December 2009. Rejuvenation Res, 2009; 12:463–467.
7.
de GreyADNJ. Commentary on some recent theses relevant to combating aging: February 2010. Rejuvenation Res, 2010; 13:119–122.
8.
de GreyADNJ. Commentary on some recent theses relevant to combating aging: August, 2010. Rejuvenation Res, 2010; 13:493–497.
9.
de GreyADNJ. Commentary on some recent theses relevant to combating aging: October 2010. Rejuvenation Res, 2010; 13:613–617.
10.
de GreyADNJ. Commentary on some recent theses relevant to combating aging: December 2010. Rejuvenation Res, 2010; 13:755–758.
11.
PeifferJJ, GalvãoDA, GibbsZ, SmithK, TurnerD, FosterJ, MartinsR, NewtonRU. Strength and functional characteristics of men and women 65 years and older. Rejuvenation Res, 2010; 13:75–82.
12.
FryCS, GlynnEL, DrummondMJ, TimmermanKL, FujitaS, AbeT, DhananiS, VolpiE, RasmussenBB. Blood flow restriction exercise stimulates mTORC1 signaling and muscle protein synthesis in older men. J Appl Physiol, 2010; 108:1199–1209.
ForgacsG, NorotteC, MargaF. Organ engineering by bioprinting. Rejuvenation Res, 2009; 12:S28.
15.
AwadHA, ZhangX, ReynoldsDG, GuldbergRE, O'KeefeRJ, SchwarzEM. Recent advances in gene delivery for structural bone allografts. Tissue Eng, 2007; 13:1973–1985.
16.
BallouB, LagerholmBC, ErnstLA, BruchezMP, WaggonerAS. Noninvasive imaging of quantum dots in mice. Bioconjug Chem, 2004; 15:79–86.
17.
Sangamo Biosciences. Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients. www.clinicaltrials.gov/ct2/show/NCT01044654NLM Identifier: NCT01044654/.
